ClearPoint Neuro, Inc. Announces Appointment of Ellisa Cholapranee as General Counsel
March 24, 2021 16:05 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., March 24, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2020 Results
March 04, 2021 16:05 ET | ClearPoint Neuro, Inc.
Company Reports Record Revenues IRVINE, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021
February 19, 2021 16:05 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips
February 18, 2021 16:05 ET | ClearPoint Neuro, Inc.
Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint ‘Maestro™’ Brain Model by 2022 IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT)...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro, Inc. Announces Multi-Product Joint Development & Option Agreement with Blackrock Microsystems
February 11, 2021 16:05 ET | ClearPoint Neuro, Inc.
IRVINE, Calif. and SALT LAKE CITY, Utah, Feb. 11, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro, Inc. Announces Expansion of Pre-Clinical and Translational Development Team to Support Gene and Stem Cell Therapy Partners
January 26, 2021 16:05 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced...
ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe
January 14, 2021 16:05 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today reported the...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro, Inc. Announces Funding of Additional $7.5M of Existing Convertible Note on Improved Terms
December 29, 2020 16:15 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro Announces Transition Plan for New Chief Financial Officer
September 14, 2020 16:15 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) is pleased to announce that global medical device financial executive Danilo D’Alessandro has been appointed...